Anastasia Velentza

Anastasia Velentza is the Founder of AVeNew Insights LLC, providing consultancy services and advice in Drug Discovery. With experience as Senior Director at Plexium and in previous roles at Ferring Pharmaceuticals, Dart NeuroScience LLC, Helicon Therapeutics, and GNF, Anastasia has a strong background in the industry. Anastasia holds a PhD in Bioorganic Chemistry from the University of Patras and has also completed a Postdoctoral Scholar program in Kinase Drug Discovery at Northwestern University. Anastasia's expertise includes leading discovery technology departments, managing teams, developing assays, and strategic project leadership.